Skip to main content
. Author manuscript; available in PMC: 2016 Nov 1.
Published in final edited form as: J Immunol. 2015 Sep 28;195(9):4524–4536. doi: 10.4049/jimmunol.1401990

Figure 1. HCT recipient characteristics.

Figure 1

A list of HCT recipients including information on conditioning regime, type of leukemia and CMV status. HCT recipients were aged 28–61, median age, 44.